COVID-19 antivirals arrive in South Jersey, in limited supply | Local News


FILE – This undated image provided by Pfizer in November 2021 shows the company’s COVID-19 pills. On Tuesday, December 14, 2021, Pfizer said its experimental COVID-19 pill is effective against the omicron variant and maintained promising early performance against the virus in final testing. (Pfizer via AP, file)


Shipments of three approved COVID-19 antiviral drugs have arrived in South Jersey, but supplies are behind schedule.

According to an interactive map from the U.S. Department of Health and Human Services, seven sites in Ocean, Atlantic, Cape May, and Cumberland counties have limited supplies of the three therapeutics recently approved as COVID-19 treatments.

Locations range from hospitals to pharmacies.

The map allows users to search for shipping and availability details, allowing them to track which pharmacies, doctor’s offices, and hospitals have the drugs.

Molnupiravir, made by New Jersey-based Merck, is the most widely distributed of the three in the Garden State, with 6,540 courses awarded and 6,440 available. Paxlovid, from Pfizer, which produced the first fully licensed COVID-19 vaccine, remains the most limited drug in the state, with 1,100 courses awarded and 356 available.

Both pills have been proven to reduce serious illnesses caused by the disease.

Finally moving from the 20th century into the 21st century, the New Jersey WIC program is evolving…

Evusheld, made by AstraZeneca, also offers 435 courses. It is approved for certain adult and pediatric uses prior to infection or exposure to COVID-19, according to the FDA.


Comments are closed.